| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
AXSM
Axsome Therapeutics
|
Jun 17, 2026 | BUY |
Strong Buy
-10.5% avg upside
28 analysts
|
$258.00
3.03% Upside
|
· |
|
JAZZ
Jazz Pharmaceuticals
|
Jun 16, 2026 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
$301.00
34.06% Upside
|
· |
|
ALKS
Alkermes
|
Jun 16, 2026 | BUY |
Strong Buy
-17.5% avg upside
34 analysts
|
$43.00
4.47% Downside
|
+2.9% |
|
AMGN
Amgen
|
Jun 12, 2026 | BUY |
Buy
-11.6% avg upside
57 analysts
|
$427.00
26.40% Upside
|
-5.0% |
|
TEVA
Teva Pharmaceutical
|
Jun 10, 2026 | BUY |
Buy
-6.8% avg upside
39 analysts
|
$42.00
33.44% Upside
|
-3.0% |
|
VTRS
Viatris
|
Jun 04, 2026 | HOLD |
Buy
+48.2% avg upside
21 analysts
|
$12.00
21.98% Downside
|
-1.2% |
|
AMRX
Amneal Pharmaceuticals
|
Jun 04, 2026 | BUY |
Strong Buy
+5.6% avg upside
18 analysts
|
$17.00
4.85% Upside
|
+20.4% |
|
SUPN
Supernus Pharmaceuticals
|
Jun 04, 2026 | BUY |
Strong Buy
+22.1% avg upside
7 analysts
|
$66.00
48.80% Upside
|
· |
|
BMY
Bristol-Myers Squibb
|
Jun 03, 2026 | BUY |
Buy
+9.1% avg upside
42 analysts
|
$75.00
38.90% Upside
|
+1.0% |
|
ABBV
AbbVie
|
Jun 02, 2026 | BUY |
Buy
+2.8% avg upside
43 analysts
|
$298.00
37.64% Upside
|
+2.7% |
|
CORT
Corcept Therapeutics
|
Jun 01, 2026 | BUY |
Buy
-45.6% avg upside
15 analysts
|
$88.00
10.22% Upside
|
+16.1% |
|
BIIB
Biogen
|
May 29, 2026 | BUY |
Strong Buy
+25.1% avg upside
51 analysts
|
$225.00
14.48% Upside
|
+1.4% |
|
INDV
Indivior
|
May 22, 2026 | BUY |
Strong Buy
+2.1% avg upside
9 analysts
|
$59.00
54.11% Upside
|
+1.1% |
|
FENC
Fennec Pharmaceuticals
|
May 15, 2026 | BUY |
Strong Buy
+78.1% avg upside
9 analysts
|
$18.00
98.71% Upside
|
-7.9% |
|
AQST
Aquestive Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+91.1% avg upside
10 analysts
|
$8.00
69.76% Upside
|
+3.2% |
|
AMPH
Amphastar Pharmaceuticals
|
May 11, 2026 | HOLD |
Hold
+41.2% avg upside
11 analysts
|
$21.00
11.73% Upside
|
· |
|
DFTX
Definium Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+45.0% avg upside
20 analysts
|
$48.00
95.99% Upside
|
+10.8% |
|
NBIX
Neurocrine
|
May 06, 2026 | BUY |
Strong Buy
+7.8% avg upside
37 analysts
|
$207.00
30.80% Upside
|
+8.7% |
|
ESPR
Esperion
|
May 01, 2026 | HOLD |
Buy
+701.2% avg upside
22 analysts
|
$3.16
0.25% Upside
|
+1.3% |
|
OGN
Organon
|
Apr 28, 2026 | HOLD |
Sell
+10.6% avg upside
9 analysts
|
$14.00
4.30% Upside
|
+0.9% |
|
COLL
Collegium Pharmaceutical
|
Apr 23, 2026 | HOLD |
Strong Buy
+25.7% avg upside
8 analysts
|
$44.00
31.16% Upside
|
+4.7% |
|
ANIP
ANI Pharmaceuticals
|
Apr 23, 2026 | BUY |
Strong Buy
+28.6% avg upside
11 analysts
|
$111.00
39.68% Upside
|
-0.1% |
|
HRMY
Harmony Biosciences Holdings
|
Apr 22, 2026 | BUY |
Strong Buy
+39.5% avg upside
13 analysts
|
$46.00
38.32% Upside
|
-5.9% |
|
PTHS
Pelthos Therapeutics
|
Apr 20, 2026 | BUY |
Strong Buy
+97.3% avg upside
8 analysts
|
$48.00
65.61% Upside
|
+12.4% |
|
XERS
Xeris Pharmaceuticals
|
Nov 07, 2025 | HOLD |
Strong Buy
+33.7% avg upside
10 analysts
|
$8.00
15.06% Upside
|
-7.1% |
|
PCRX
Pacira Pharmaceuticals
|
Nov 07, 2024 | HOLD |
Buy
+74.3% avg upside
21 analysts
|
$12.00
46.28% Downside
|
+24.6% |
|
TSE:BHC
Bausch Health Companies
|
Oct 31, 2024 | SELL |
Buy
+783.6% avg upside
29 analysts
|
$4.20
37.70% Downside
|
· |
|
IRWD
Ironwood Pharma
|
May 22, 2024 | BUY |
Hold
+235.8% avg upside
23 analysts
|
$18.00
408.54% Upside
|
-90.5% |
|
TVRD
Tvardi Therapeutics
|
May 14, 2024 | HOLD |
Buy
+588.1% avg upside
23 analysts
|
$12.00
356.20% Upside
|
+1.1% |
|
EGRX
Eagle Pharmaceuticals
|
Aug 09, 2023 | SELL |
Sell
+3965.0% avg upside
2 analysts
|
$17.00
2664.14% Upside
|
+78.7% |
|
EVFM
Evofem Biosciences
|
May 25, 2022 | BUY |
Buy
+269017.6% avg upside
8 analysts
|
$2.00
23429.37% Upside
|
· |
|
VYNE
VYNE Therapeutics
|
Nov 10, 2021 | BUY |
Strong Buy
+2024.6% avg upside
9 analysts
|
$3.00
372.18% Upside
|
-80.9% |
|
BXRXQ
Baudax Bio
|
May 06, 2021 | BUY |
Strong Buy
+18749999900.0% avg upside
3 analysts
|
$175.00
17499999899.95% Upside
|
· |
|
NOVN
Novan
|
Jan 05, 2020 | HOLD |
Buy
6 analysts
|
$0.50
|
· |
|
PFE
Pfizer
|
Jan 23, 2019 | HOLD |
Buy
+34.1% avg upside
45 analysts
|
— | +0.1% |
|
ASRT
Assertio Therapeutics
|
Nov 08, 2018 | HOLD |
Buy
-8.8% avg upside
13 analysts
|
$5.00
78.67% Downside
|
-85.6% |
|
TLPH
Talphera
|
Oct 12, 2017 | HOLD |
Buy
+339.6% avg upside
15 analysts
|
$2.00
83.45% Upside
|
+85.1% |
|
WINT
Windtree Therapeutics
|
Nov 11, 2013 | BUY |
Strong Buy
+40610.2% avg upside
6 analysts
|
$6.00
35214.85% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.